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Abstract: The geographic position, highly fluctuating sea temperatures and hypersalinity make Persian
Gulf an extreme environment. Although this unique environment has high biodiversity dominated by
invertebrates, its potential in marine biodiscovery has largely remained untapped. Herein, we aimed at
a detailed analysis of the metabolome and bioactivity profiles of the marine sponge Axinella sinoxea
collected from the northeast coast of the Persian Gulf in Iran. The crude extract and its Kupchan subextracts
were tested in multiple in-house bioassays, and the crude extract and its CHCl3-soluble portion showed
in vitro antibacterial activity against Methicillin-resistant Staphylococcus aureus (MRSA) and Enterococcus
faecium (Efm). A molecular networking (MN)-based dereplication strategy by UPLC-MS/MS revealed
the presence of phospholipids and steroids, while 1H NMR spectroscopy indicated the presence of
additional metabolites, such as diketopiperazines (DKPs). Integrated MN and 1H NMR analyses on both
the crude and CHCl3 extracts combined with an antibacterial activity-guided isolation approach afforded
eight metabolites: a new diketopiperazine, (-)-cyclo(L-trans-Hyp-L-Ile) (8); a known diketopiperazine,
cyclo(L-trans-Hyp-L-Phe) (7); two known phospholipids, 1-O-hexadecyl-sn-glycero-3-phosphocholine
(1) and 1-O-octadecanoyl-sn-glycero-3-phosphocholine (2); two known steroids,
3β-hydroxycholest-5-ene-7,24-dione (3) and (22E)-3β-hydroxycholesta-5,22-diene-7,24-dione (4); two known
monoterpenes, loliolide (5) and 5-epi-loliolide (6). The chemical structures of the isolates were elucidated by
a combination of NMR spectroscopy, HRMS and [α]D analyses. All compounds were tested against MRSA
and Efm, and compound 3 showed moderate antibacterial activity against MRSA (IC50 value 70 µg/mL).
This is the first study that has dealt with chemical and bioactivity profiling of A. sinoxea leading to isolation
and characterization of pure sponge metabolites.
Keywords: marine sponge; Axinella sinoxea; Persian Gulf; molecular networking; 1H NMR spectroscopy;
diketopiperazine; steroid; monoterpene
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1. Introduction
Iranian coastline totals 1700 km and borders the Persian Gulf and Gulf of Oman (GO) in
the northwest Indian Ocean. The Gulf of Oman is an exposed and deep component of the Arabian
Sea in the northwest Indian Ocean, while the Persian Gulf is a warm, shallow and enclosed sea
separated from the Arabian Sea by the GO. The Persian Gulf is an extension of the Indian Ocean and is
connected to the GO by the Strait of Hormuz. The average depth of the Persian Gulf is around 35 m,
and the maximum depth can reach 100 m. Due to extreme aridity and high summer temperatures
up to 48 ◦C, water surface temperature fluctuates between 12 to 35 ◦C [1,2]. The evaporation of
the Persian Gulf exceeds freshwater input tenfold (commonly measured at 40–50 ppt and up to
70 ppt in shallow, enclosed bays) leading to high salinity. These natural pressures, as well as high
anthropogenic stress due to industrialization and urbanization, render the Persian Gulf an extreme
environment [2]. Nevertheless, the fauna of the Persian Gulf is still highly diverse and dominated by
the sponge and coral communities. A recent study has investigated the sponge diversity of the Persian
Gulf collected from Iran [3]. However, the chemistry and biomedical potential of sponges inhabiting
the Persian Gulf have remained largely untapped so far.
The sponges of the family Axinellidae are common in many oceans, such as the Indian and Pacific
Oceans, including the Persian Gulf. Axinella is a large sponge genus comprising 183 species [4].
The members of this genus are prolific sources of a wide array of natural product classes, such as steroids,
sesquiterpenoids, diterpenoids, alkaloids, polyethers and cyclic peptides (including DKPs) [5–10].
The extracts, as well as secondary metabolites isolated from Axinella species, have been reported to
exhibit diverse biological activities, with antimicrobial [7,8] and anticancer activities [11–13] being
probably the most common ones. In the Persian Gulf, the genus Axinella is represented by a single
species, A. sinoxea [13]. As part of our project aiming at in-depth metabolome and bioactivity profiling
of Persian Gulf sponges, we have selected A. sinoxea that Alvarez and Hooper, 2009 collected from
Larak Island (Iran) for comprehensive chemical studies. The crude MeOH extract was screened
for biological activities, namely antimicrobial (against the bacterial ESKAPE panel and two fungi)
and anticancer (against six human cancer cell lines and one non-cancerous cell line). The crude
MeOH extract of the sponge and its CHCl3-soluble portion showed considerable antibacterial activity.
Hence, we applied an integrated metabolomics approach using both HRMS/MS-based molecular
networking and 1H NMR spectroscopy to map chemical diversity of the sponge and combined this
strategy with a bioactivity-guided isolation procedure for targeted isolation of bioactive and chemically
interesting metabolites. This report outlines the chemical and bioactivity profiling of the sponge extracts
followed by purification, characterization and bioactivity assessment of compounds 1–8 isolated from
A. sinoxea.
2. Results
2.1. Bioactivity Profiling
The sponge material was extracted with MeOH and screened for its in vitro biological activities,
including antimicrobial activity against the bacterial ESKAPE panel, i.e., Enterococcus faecium (Efm),
methillicin-resistant Staphylococcus aureus (MRSA), Klebsiella pneumoniae, Acinetobacter baumannii,
Pseudomonas aeruginosa and Escherichia coli; for antifungal activity against Candida albicans
and Cryprococcus neoformans, and for anticancer activity against six cancer cell lines including lung
carcinoma cell line A549, colorectal adenocarcinoma cell line HT29, malignant melanoma cell line A375,
liver cancer cell line Hep G2, colon cancer cell line HCT116, human breast cancer line MDA-MB231,
plus the non-cancerous human keratinocyte cell line HaCaT. The only high activity demonstrated by
the crude MeOH extract was against MRSA (78% inhibition at 100 µg/mL) (Figure 1). The crude extract
was partitioned between n-hexane, chloroform and aqueous methanol through a modified Kupchan
method [14]. The CHCl3 subextract retained the anti-MRSA activity and displayed a low antibacterial
potency against Efm (62% and 33% inhibition at 100 µg/mL, respectively). This subextract was
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fractionated by C18 flash chromatography to yield 12 fractions (C1–C12). Repeated HPLC separations
of the most active fractions C6–C10 (Figure 1) monitored by anti-MRSA and anti-Efm activities yielded
compounds 1–6, while compounds 7 and 8 were isolated from the inactive fraction C1 monitored by
the 1H NMR profiling.
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Figure 1. Comparative in vitro activity (% inhibition at 100 µg/mL) of the crude MeOH extract, CHCl3
subextract and its C18 fractions against Staphylococcus aureus (MRSA) and Enterococcus faecium (Efm).
Positive controls: chloramphenicol (MRSA) and ampicillin (Efm). Solvent control: 0.5% dimethyl
sulfoxide (DMSO).
2.2. Molecular Networking-Based Dereplication and 1H NMR Profiling
Both molecular networking (MN)-based automated and manual dereplication strategies by tandem
UPLC-QToF-MS in positive-ion mode were applied for comprehensive metabolite profiling of the crude
extract. For data examination purposes, the Global Natural Products Social Molecular Networking
(GNPS; www.gnps.ucsd.edu) platform was used [15]. The outcoming MN was visualized via the free
software Cytoscape 3.6.1., wherein 12 sub-networks (at least two nodes per cluster) composed of 68
nodes were observed (Figure 2). Not all these nodes correspond to a single molecule as some represent
isotopes or adducts. As shown in Figure 2, automated dereplication using the GNPS platform assisted
the annotation of two large molecular clusters belonging to phosphatidylcholine (A, blue nodes)
and cholesterol (B, green nodes).
Cluster A contained 23 nodes, corresponding to 13 molecules (Figure 2A).
Automated dereplication on the GNPS platform allowed the annotation of
five known phospholipids, i.e., 1-O-heptadecyl-sn-glycero-3-phosphocholine (m/z
496.314 [M + H]+), 1-(1Z-hexadecenyl)-sn-glycero-3-phosphocholine (m/z 480.321
[M + H]+), 1-O-octadecanoyl-sn-glycero-3-phosphocholine (m/z 524.349 [M + H]+)
(2), 1-arachidoyl-2-hydroxy-sn-glycero-3-phosphocholine (m/z 552.379 [M + H]+)
and 1-O-hexadecyl-sn-glycero-3-phosphocholine (m/z 482.339 [M + H]+) (1) [16–18]. Another node at m/z
498.316 (square node, Figure 2A), connected to the known phosphocholine subnetwork with thick edges, was
annotated as a putative new phosphocholine analogue as its molecular formula did not match any known
compound from this chemical family in a comprehensive database search. Given the elemental composition
analysis, biological source and fragmentation patterns, manual dereplication allowed the annotation of
all other nodes in cluster A as known phospholipids with varied chain length and unsaturation (Table
S1). Cluster B was annotated as a cholesterol type steroid family based on the elemental composition
analysis and MS2 fragmentation patterns (Figure 2B). Of the 21 nodes observed in cluster B, one
was automatically annotated as the known compound 7-ketocholesterol (m/z 401.316 [M + H]+) [19]
via the GNPS platform. Six nodes at m/z 445.306, 457.306, 459.321, 417.312, 417.303 and 397.302
(square nodes, Figure 2B, all m/z values are [M + H]+), were annotated as putative new cholesterol
derivatives based on their similar fragmentation patterns to that of 7-ketocholesterol and the absence
of formula matches to any known cholesterols in multiple databases. All remaining nodes in B were
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dereplicated as known cholesterol analogues manually on the basis of their fragmentation patterns,
elemental composition analysis and biological source, e.g., 3β-hydroxycholest-5-ene-7,24-dione
(m/z 415.297 [M + H]+) (3) and (22E)-3β-hydroxycholesta-5,22-diene-7,24-dione (m/z 413.316 [M + H]+)
(4) (Figure 2B) [20]. The supplementary Table S1 demonstrates the detailed MS data of the other
annotated steroids.
Figure 2. Global molecular network (MN) of the crude extract of A. sinoxea. (A) Phospholipid cluster
(highlighted in blue). (B) Steroid cluster (highlighted in green). Numbers within the nodes indicate
parent ions, and edge thickness represents the cosine similarity between nodes. Square nodes represent
putative new compounds.
Apart from the networks A and B, ten small clusters with two or three nodes were visible in
the global MN of the crude MeOH extract (Figure 2, the grey networks). They remained unannotated,
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by both automated and manual dereplication efforts, indicating them to represent putatively new
chemical families and compounds.
The CHCl3 subextract was also profiled by tandem MS, resulting in altogether 11 clusters (at least
two nodes per cluster) that were composed of 72 nodes (Figure S1). Similar to the crude MeOH extract,
two big clusters (A1 and B1) dominated the global MN profile. The clusters A1 and B1 were also
annotated as phospholipids and cholesterols, respectively, via automated dereplication on the GNPS
platform. Cluster A1 contained 29 nodes, generated by 13 molecules, and cluster B1 consisted of 22
nodes, corresponding to 12 molecules. In-depth manual dereplication revealed the composition of
both clusters A1 and B1 to the same as that of clusters A and B observed in the global MN of the crude
MeOH extract of A. sinoxea (Table S1). Remaining small clusters in the global MN (Figure S1) could not
be annotated to any known chemical classes, either by automated or manual dereplication methods.
Since MS-based profiling yielded only limited information on the chemical inventory of A. sinoxea,
we decided to investigate the crude extract and the CHCl3 subextract by 1H NMR spectroscopy. The 1H
NMR spectrum of the crude MeOH extract (Figure S2) contained resonances typical for aliphatic
lipids (approx. δH 1.0–2.5), methyl signals due to steroids (δH 0.7–1.2), double bonds of unsaturated
lipids/fatty acids (δH 5.3) as well as complex aromatic signals (δH 7.1–7.2) and heteroatom-bearing
proton signals (δH 3.2–4.5). The 1H NMR spectrum of the CHCl3 subextract was also highly similar
(Figure S3). It contained predominant signals in the aromatic region (δH 7.0–7.2) and several sharp
heteroatom-neighboring protons (δH 3.2–3.5 and 4.0–4.5) that were reminiscent of α-methine protons
of amino acids and DKPs [21,22]. The information gained from the 1H NMR spectrum of the crude
and the CHCl3 extracts indicated that metabolome of the sponge was richer and UPLC-MS/MS-based
profiling did not reflect the full chemical machinery of the sponge. Therefore, both methods were
used for activity-guided purification of the CHCl3 subextract fractions (C6-C10). We also purified
the inactive fraction C1 as the amino acid type signals observed in the 1H NMR spectrum were tracked
to this fraction.
2.3. Purification and Structure Elucidation
The CHCl3 subextract with antibacterial activity was profiled by MN and 1H NMR spectroscopy.
Reverse-phase (C18) flash column chromatography of the CHCl3 subextract yielded 12 fractions, out
of which five showed antimicrobial activities (frs. C6–C10, Figure 1). All bioactive fractions were
further submitted to RP-HPLC for purification. The chemical structures of the purified compounds
were identified based on the comparison of their 1D and 2D NMR, HR-ESIMS data including MS2
fragmentation patterns and [α]D data with those reported in the literature (Figures S4–S33). MN profiling
was very useful for the targeted isolation of phospholipids 1-O-hexadecyl-sn-glycero-3-phosphocholine
(m/z 482.339 [M + H]+) (1) [16] and 1-O-octadecanoyl-sn-glycero-3-phosphocholine (m/z 524.349
[M + H]+) (2) [17] (cluster A, Figure 2) as well as the steroids 3β-hydroxycholest-5-ene-7,24-dione
(m/z 415.297 [M + H]+) (3) and (22E)-3β-hydroxycholesta-5,22-diene-7,24-dione (m/z 413.316 [M + H]+)
(4) (cluster B, Figure 2) [20] from fractions C7–C10. In turn, 1H NMR spectroscopy was particularly
helpful for guiding the isolation of the known (7) and the new (8) DKPs, which existed in the inactive
fraction C1 and showed diagnostic resonances in the 1H NMR spectrum of the crude and the CHCl3
subextract (Figures S2 and S3) [22]. Finally, two monoterpenes loliolide (5) and 5-epi-loliolide (6) [23,24]
which did not appear in the MN because of their low MS2 fragmentation intensity were also isolated
from the active fraction C6 (Figure 3).
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Figure 3. Chemical structure of compounds 1–8.
Compound 8 was obtained as a colorless film. Its molecular formula C11H18N2O3 was deduced
by HR-ESIMS (m/z 227.1407, [M + H]+) (Figure S33) indicating 4 degrees of unsaturation (DoU).
The 1H and 13C NMR spectra (CD3OD) showed the presence of two carbonyl groups at δC 167.7 (C-1)
and 172.7 (C-7), plus two α-methine protons at δH 4.48 (H-6) and 4.13 (H-9) that resonated at δC 58.3
and 61.2, respectively, suggesting 8 to be a dipeptide [22]. Additionally observed in the 1D NMR
spectra (CD3OD) were one methine (δH 2.18, H-10; δC 36.9, C-10), one oxymethine (δH 4.47, H-4; δC
68.8, C-4) and three methylene protons [δH 3.72, 3.42, H2-3; δC 55.1, C-3; δH 2.29, 2.04, H2-5; δC 38.6,
C-5; and δH 1.46, 1.33, H2-11; δC 25.4, C-11] as well as a secondary methyl (δH 1.08 d, J = 7.3 Hz,
H3-13; δC 15.4, C-13) and a terminal methyl (δH 0.94 t, J = 7.4 Hz, H3-12; δC 12.5, C-12) group (Table 1).
The 1H NMR spectrum acquired in DMSO-d6 revealed the presence of two exchangeable protons at
δH 5.13 and 7.97 (Figure S25). Considering the molecular formula, DoU and comparison of the NMR
and MS data with those of 7, compound 8 was identified as a bicyclic diketopiperazine derivative [22].
The major difference between the two compounds was that 8 lacked the aromatic signals belonging to
the phenylalanine residue found in 7. To confirm the amino acid composition and identify the planar
structure of 8 unambiguously, we acquired COSY and HMBC spectra of 8. The COSY spectrum of 8
contained two spin systems (Figure 4A). The first one contained a proton network from C-3 to C-6
(Figure 4A). The strong COSY correlation of both H2-3 and H2-5 with the oxymethine proton H-4
indicated the position of the hydroxy-group at C-4. This was further confirmed by the diagnostic
HMBC correlations of H2-3 with C-4 and C-5, of H-4 with C-6 and of H2-5 with C-3. The HMBC
spectrum showed further correlations of both H2-5 and H-6 with the C-7 carbonyl group (Figure 4A).
Hence, the first amino acid unit within the DKP scaffold was confirmed as hydroxyproline (Hyp).
The second COSY spin system that included the proton network from H-9 to terminal H3-12 was
identified as a secondary butyl group (Figure 4A). Therein, the α-methine proton (H-9) coupled
with H-10 of the sec-butyl group spectrum, indicating the presence of an isoleucine (Ile) moiety as
the second amino acid. This was further supported by the key HMBC correlations between H-9/C-11
and H3-13/C-9 (Figure 4A). Further HMBC correlations between H2-3/C-1 and H-9/C-7 completed
the DKP ring system (Figure 4A). Thus, the planar structure of 8 was elucidated as cyclo(Hyp-Ile).
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Figure 4. Key COSY (bold) and HMBC correlations H→C (arrows) (A) and key NOESY correlations
(dashed line, B) observed for compound 8.
The relative configuration of the stereocenters within 8 was deduced with the aid of the NOESY
spectrum, [α]D value and comparison with data published in the literature. The observed NOE
cross-peak between H-6 and H-9 indicated these protons to be on the same side (α) of the molecule
(Figure 4B). The lack of any NOESY correlation between H-4 and H-6 suggested the opposite (β)
orientation of H-4. The relative configuration of C-10 was assigned by comparison of the 1H
and 13C NMR data of 8 with those of structurally similar compounds containing the isoleucine
group [25,26]. A literature survey indicated that 8 shares identical NMR data with the known
DKP, cyclo(D-trans-Hyp-D-Ile) isolated from the marine sponge Stelletta sp. [27], hence, these two
compounds should share the same planar structure and relative configurations. However, compound
8 displayed a negative specific rotation value ([α]20D -84, c 0.1, CHCl3) whereas the sign of the [α]D
value for the known metabolite cyclo(D-trans-Hyp-D-Ile) was positive ([α]21D +12, c 0.025, CHCl3).
Compound 8 was highly pure by NMR spectroscopy (Figures S25–S32) and HPLC-DAD-ELSD analysis
on a chiral column, and the repeated [α]D measurements gave the same negative optical sign and value.
We conclude that compound 8 is the enantiomer of cyclo(D-trans-Hyp-D-Ile) [27] where both amino acid
units are enantiomeric to the known compound. Hence, compound 8 is (-)-cyclo(L-trans-Hyp-L-Ile).
Table 1. 1H NMR (600 MHz) and 13C NMR (150 MHz) data of compound 8 in MeOD.
Position δH, Mult. (J in Hz) δC, Type
1 - 167.7 (C)
3 3.72 (dd 12.9, 4.6)3.42 (m) 55.1 (CH2)
4 4.47 (m) 68.8 (CH)
5 2.29 (m)2.04 (ddd 13.3, 11.7, 4.3) 38.6 (CH2)
6 4.48 (m) 58.3 (CH)
7 - 172.7 (C)
9 4.13 (br s) 61.2 (CH)
10 2.18 (m) 36.9 (CH)
11 1.46 (m)1.33 (m) 25.4 (CH2)
12 0.94 (t 7.4) 12.5 (CH3)
13 1.08 (d 7.3) 15.4 (CH3)
2.4. Bioactivity of Compounds 1–8
All purified compounds (1–8) were tested against MRSA and Efm for their antimicrobial activities.
Only 3β-hydroxycholest-5-ene-7,24-dione (3) showed moderate activity against MRSA with an IC50
value of 70 µg/mL. All other compounds were inactive at the highest test concentrations (100 µg/mL).
3. Discussion
The present study that involved an in-depth metabolomic study employing both HRMS/MS-based
molecular networking and 1H NMR spectroscopy revealed the great chemical machinery of the marine
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sponge A. sinoxea originated from the Persian Gulf. Guided by two spectroscopic profiling methods
in an integrated manner and combined with antimicrobial activity, eight compounds belonging to
four different chemical families were isolated and chemically characterized. MN-based metabolomics
also revealed the presence of several putatively new compounds, which we were not able to purify in
sufficient quantities for spectroscopic analyses, further pointing out the untapped potential of Axinella
sponges in marine biodiscovery.
Although the sponge genus Axinella is well-known for being a prolific producer of chemically
diverse metabolites with promising bioactivities [5–8], A. sinoxea has remained a poorly studied species.
Until now, only five reports dealing with chemical or biological investigations of A. sinoxea sponge are
available in the literature [11–13,28,29]. All these studies were performed on sponge material collected
from the Persian Gulf where the genus Axinella is represented by a single species, A. sinoxea. The very
first study by Nazemi et al. in 2012 observed minimal antibacterial activity of the diethyl ether extract
of A. sinoxea against Bacillus subtilis spizizenii and S. aureus [28]. Studies by Mahdian et al. (2015) [29]
and Nazemi et al. (2020) [13] revealed moderate cytotoxicity of the nonpolar extracts of A. sinoxea,
while Salimi et al. (2015) reported the selective apoptotic effect of standardized A. sinoxea methanolic
extract in human chronic lymphocytic leukemia cells [11]. A very recent study by Jamebozorgi et al.
(2019) investigated the fatty acid and steroid composition of A. sinoxea by GC-MS to identify several
saturated and unsaturated fatty acids and eight known steroids belonging to cholesterol, ergosterol,
stigmasterol and norgorgosterol subclasses [12]. None of these identified compounds were purified
or tested for their bioactivities. However, the fatty acid and steroid containing fractions displayed
a significant inhibitory activity against human cancerous and non-cancerous cell lines. In the present
study, A. sinoxea extracts did not inhibit any of the six cancer cell lines or the non-cancerous human
keratinocyte cell line HaCaT. To our knowledge, this is the first study employing in-depth metabolomics,
bioactivity screening and an activity-guided isolation procedure on A. sinoxea. Additionally, for the first
time, purified and chemically characterized natural products are being reported from the same sponge.
One major aim of this study was to profile the potential biological activities of A. sinoxea
collected from the Persian Gulf in a number of in-house bioassays. Notably, the crude extract and its
CHCl3-soluble portion displayed only in vitro antimicrobial activity against MRSA. The C18 flash
chromatography fractions of the CHCl3-extract also inhibited the growth of Efm. However, after
completion of the bioactivity-guided isolation process on the active fractions, none of the purified
metabolites showed any effect against Efm, and only one compound (3) was moderately active
towards MRSA. It is a common problem that the activity of natural extracts diminishes or becomes
completely lost due to the lack of synergistic effects of various components after a long and tedious
purification process of individual constituents. On the other hand, we have performed the very first
and comprehensive metabolomics study on A. sinoxea with the aid of a modern and automated tool
such as Molecular Networking (MN) in combination with a classical, but rapid and non-destructive
chemical profiling method, 1H NMR spectroscopy. Molecular networking (MN) is a tandem mass
spectrometry (MS2)-based metabolomics methodology performed on the open-access online platform
Global Natural Products Social Molecular Networking (GNPS). It provides the ability to match
tandem mass (MS2) spectrometry data from the users to GNPS spectral libraries to achieve an efficient
automated dereplication. More importantly, MN is able to map out the chemical space of a biological
sample by grouping similar metabolites that produce similar MS/MS fragmentation in one cluster [15].
Our research group has been using MN successfully to uncover the detailed chemical machinery
of various marine macro- and micro-organisms followed by targeted isolation of new and bioactive
marine natural products [14,30,31]. However, in the current study, MN provided limited information
on the chemical composition of A. sinoxea and only two natural product families, i.e., phospholipids
and steroids, which are the major components of sponge cell walls [32], have been annotated. This might
be due to the low MS/MS fragmentation intensity or the lower abundances of the other metabolites in
crude mixtures. The 1H NMR spectroscopy is, however, a universal method, where one can observe
all types of proton resonances in an organic compound. The main limitation of the method is its
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low sensitivity, hence, 1H NMR spectra of natural extracts are generally dominated by the signals
of primary molecules that are highly abundant in every organism. However, 1H NMR spectroscopy
becomes more helpful after the solvent–solvent partition and fractionation of the crude extract, where
most of the primary metabolites are removed and secondary metabolites that are generally produced
in small quantities become readily visible for monitoring the purification steps.
It is well known that sponges contain many lipid compounds, such as sterols and phospholipids [33].
Since the first report of steroids from marine sponges by Bergman in 1949 [34], numerous reports
have described conventional and unconventional steroids from demosponges with modifications on
the tetracyclic nucleus or the side chain, including e.g., aminosteroids, sulfated polyhydroxysterols,
side-chain-oxygenated sterols and sulfated steroid-amino acid conjugates [20,33,35–37].
Axinella sponges are known to have generally complex steroid profiles including steroids
and nor-steroids [36,38,39]. The previous GC-MS study on A. sinoxea led to the identification of
eight steroidal compounds: cholesta-5,22-dien-3β-ol, cholest-5-en-3β-ol, ergosta-5,22-dien-3β-ol,
ergost-5-en-3β-ol, stigmasta-5,22-dien-3β-ol, γ-sitosterol, 33-norgorgosta-5,24(28)-dien-3β-ol
and stigmasta-5,24(28)-dien-3β-ol [12]. The present study by UPLC-MS/MS annotated only
cholestane type animal steroids, namely 7-ketocholesterol, 3β-hydroxycholest-5-ene-7,24-dione (3)
and (22E)-3β-hydroxycholesta-5,22-diene-7,24-dione (4). The latter two compounds were also purified
in sufficient quantities and characterized by spectroscopic methods. The sterols primarily have
a functional role in sponges, as constituents of cell membranes and as metabolic precursors for
the biosynthesis of diverse steroid (sub)classes [35,37]. Cholesterol is a membrane stabilizer, maintaining
its integrity and adjusting its flexibility and permeability [40]. Sponge biomembranes also have a high
content of phospholipids, including plasmalogens, alkylacyl and diacyl glycerophospholipids [40,41].
Djerassi et al. showed the pathways of phospholipid metabolism (from glycerol-3-phosphate
precursor) in the demosponge Microciona prolifera back in 1991 [40]. The phospholipid composition of
Axinella verrucosa has been identified to contain roughly a 1:1:1 mixture of phosphatidylethanolamines,
phosphatidylglycerols and phosphatidylserine [42]. From A. sinoxea, we have dereplicated
several 1-O-acyl-sn-glycerol or 1-O-alkyl-sn-glycerol type phosphatidylcholines, such as
1-O-heptadecyl-sn-glycero-3-phosphocholine, 1-(1Z-hexadecenyl)-sn-glycero-3-phosphocholine,
1-O-hexadecyl-sn-glycero-3-phosphocholine (1), 1-arachidoyl-2-hydroxy-sn-glycero-3-phosphocholine
and 1-O-octadecanoyl-sn-glycero-3-phosphocholine (2). The compounds 1–2 were isolated and their
structures were elucidated.
1H NMR profiling allowed us to observe the presence of DKPs (7, 8), small cyclic peptide
compounds, which did not appear on the MN of both crude and CHCl3 extracts of A. sinoxea.
The first DKP (7) was previously purified from the sponge-associated yeast Aureobasidium pullulans [21],
and from the endophytic bacterium Nocardiopsis sp. associated with the terrestrial plant Mallotus
nudiflorus L. [22]. The known DKP, cyclo(D-trans-Hyp-D-Ile) that is the (+)-enantiomer of our
compound 8 also originates from a marine sponge, Stelletta sp. [27]. New DKPs, such as verpacamides
A−D type C11N5 DKPs relating to cyclo(Pro-Pro) and to cyclo(Pro-Prg), but also a number of
known DKPs such as cyclo-(Pro-Thr), cyclo-(Pro-Ser), cyclo-(Pro-Ala), cyclo-(Pro-Leu), cyclo-(Pro-Val)
and cyclo-(Pro-Gly) have been reported from the genus Axinella [8]. DKPs are the smallest cyclic
peptides consisting of a minimum of twoα-amino acids [43]. DKPs are an abundant class of biologically
active natural compounds produced by a variety of marine microorganisms (bacteria, fungi, yeast)
and macroorganisms such as sponges, tunicates and red algae [43,44]. Finally, we purified and identified
two monoterpene lactone norisoprenoids, loliolide (5) and 5-epi-loliolide (6) from the CHCl3 subextract
of A. sinoxea. As degraded lactonic carotenoids, they are very common in nature and have been
reported from brown seaweeds, marine invertebrates, sediment as well as numerous terrestrial plants
and animals, even from insects [45]. We have previously identified compounds 5 and 6 in the surface
extract of the Baltic seaweed Fucus vesiculosus [46].
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4. Materials and Methods
4.1. General Experimental Procedures
Optical rotations were measured using a Jasco P-2000 polarimeter (Jasco, Pfungstadt, Germany)
equipped with a sodium lamp (589 nm). NMR spectra were obtained on a Bruker AV 600 spectrometer
(600 and 150 MHz for 1H and 13C NMR, respectively) equipped with a triple resonance cryoprobe.
The spectra were acquired at 298 K (25 ◦C). The samples were dissolved in 300 µL of deuterated
solvent using a 5.0 mm Shigemi tube. The residual solvent signals were used as internal references:
δH 7.26/δC 77.2 ppm (CDCl3), δH 3.31/δC 49.0 ppm (MeOD) and δH 2.50/δC 39.5 ppm (DMSO-d6).
Tetramethylsilane (TMS) served as the internal standard. The 1H NMR spectrum (zg30) was acquired
with 8 scans, while the 13C NMR spectrum (pulseprogram: zgpg30) was measured with 8192 scans.
The COSY (pulseprogram: cosygpmfppqf) experiment was achieved with 2 scans and 1024 datapoints in
the F1-dimension using non-uniform sampling, while NOESY (pulse program: noesygpphpp, 8 scans)
was acquired with 512 in the F1 dimension. The HSQC spectrum (pulseprogram: hsqcedetgpsisp2.4)
was acquired with 16 scans and 1024 datapoints in the F1-(C)-dimension using non uniform sampling,
while the HMBC spectrum was run (pulseprogram: hmbcgplpndqf) with 24 scans and 400 datapoints
in the F1-(C)-dimension. HR-MS/MS data were recorded on a Waters Xevo G2-XS QTof Mass
Spectrometer (Waters®, Milford, MA, USA) coupled to a Waters Acquity I-Class UPLC system
(Waters®, Milford, MA, USA). HR-ESIMS was recorded on a micrOTOF II-High-performance TOF-MS
system (Bruker®, Billerica, MA, USA) equipped with an electrospray ionization source. Reversed phase
C18 silica gel (50 µm, 65Å, Phenomenex, Torrance, CA, USA) was used for column chromatography
(CC) to pre-fractionate the CHCl3 subextract. HPLC separations were performed on a VWR Hitachi
Chromaster system coupled with a diode array detector, an autosampler and a pump combined
in parallel with a VWR evaporative light scattering detector. Two solvents H2O + 0.1% FA (A)
and acetonitrile + 0.1% FA (B) ULC/MS and HPLC grade were used as the mobile phase. Routine
HPLC separations were performed on a semi-preparative C18 monolithic column (Onyx, 100 × 10
mm, Phenomenex) and an analytical synergi column (250 × 4.6 mm, Phenomenex). A chiral cellulose-1
column (Lux 5µ, 250 × 4.6 mm, Phenomenex) was used for checking the enantiopurity of each
purified compound.
4.2. Sponge Material
The sponge sample was collected by scuba diving (−15 m) from a reef habitat around Larak
Island (Persian Gulf) in June 2016. The sample was immediately frozen at −20 ◦C and transferred to
the laboratory. It was identified through a scanning optical microscope, skeletal slides and dissociated
spicule mounts based on the Hooper identification key [47]. A voucher specimen (De/Ax220) was
deposited in the Persian Gulf and Oman Sea Ecological Center.
4.3. Extraction and Isolation
The sponge material (450 g, dry wt.) was desalted by extracting with Milli-Q Water (3 × 1.5 L)
at room temperature. The sponge residue was then extracted with MeOH under agitation (3 × 1.5
L) to yield a yellowish crude organic extract (12.67 g). The methanolic extract was partitioned by
a modified Kupchan method [14] to yield n-hexane (9.01 g), CHCl3 (2.63 g) and aq. MeOH (0.93 g)
subextracts. The bioactive CHCl3-soluble fraction was subjected to C18 flash chromatography (25 µm,
250 × 20 mm i.d.) eluting with a step gradient of MeOH in H2O (0% to 100% MeOH) to afford 12
subfractions (C1–C12). The fraction C6 (58 mg) was subjected to a RP-HPLC separation on the Onyx
Monolithic Semi-PREP C18 (column 5 µm, 100 × 10 mm i.d.) eluting with a gradient of H2O + 0.1% FA
(A): MeCN + 0.1% FA (B) (75:25 to 70:30) at a flow rate of 2.5 mL/min to yield 5 (0.4 mg, tR 5.5 min)
and 6 (0.5 mg, tR 7.5 min). The separation of subfraction C7 (94 mg) at the same conditions and at
a gradient of 65% A to 60% A for 20 min afforded 3 (0.6 mg, tR 8.2 min). The subfraction C8 (122 mg)
was further purified by RP-HPLC using a gradient of 55% A to 50% A for 20 min to yield compound
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4 (0.4 mg, tR 10.4 min). The subfraction C10 (200 mg) was further separated by RP-HPLC analysis
with a gradient of 25% A to 0% A for 30 min, to give 1 (1.1 mg, tR 8.9 min) and 2 (1.2 mg, tR 10.2 min).
The subfraction C1 (15 mg) was also subjected to RP-HPLC on the Onyx Monolithic C18 (100 × 4.6
mm i.d.) column and eluted isocraticly with 95% A for 30 min at a flow rate of 1.5 mL/min to afford
compounds 7 (1.9 mg, tR 10.2 min) and 8 (1.2 mg, tR 6.2 min). The enantiopurity of all compounds was
checked by HPLC-DAD-ELSD on a chiral cellulose-1 analytical column using a gradient of MeCN
(1% to 100% for 15 min at a flow rate of 1.5 mL/min).
(-)-Cyclo(L-trans-Hyp-L-Ile) (8): colorless oil. [α]20D −84 (c 0.1, CHCl3); 1H NMR (CD3OD, 600
MHz) and 13C NMR (CD3OD, 150 MHz) see Table 1; HR-ESIMS m/z [M + H]+ 227.1407 (calcd. for
C11H19N2O3 227.1396).
4.4. UPLC-QToF-MS/MS Analysis
An ACQUITY UPLC I-Class System coupled to the Xevo G2-XS QToF Mass Spectrometer
(Waters®, Milford, Massachusetts, USA) was used to analyze the crude MeOH extract, CHCl3
subextract and C18 subfractions, which was equipped with an electrospray ionization (ESI) source
operating with a positive polarity at a mass range of m/z 50–1600 Da. The samples were dissolved
in methanol at a concentration of 0.1 mg/mL and filtered through a 0.2 µm PTFE syringe filter
(Carl Roth, Karlsruhe, Germany) and then 2 µL of each sample was injected into the system.
The separation of compounds was achieved using a binary LC solvent system controlled by MassLynx®
(version 4.1) to analyze MS and MS2 data. An Acquity UPLC HSS T3 column (high-strength silica
C18, 1.8 µm, 100 × 2.1 mm I.D., Waters®) was operated at 40 ◦C and eluted with H2O + 0.1% FA (A)
and MeCN + 0.1% FA (B) ULC/MS grade at a flow rate of 0.6 mL/min with the following gradient:
initial, 1%–100% B, 0–12 min; 100% B, 12–13 min and a column reconditioning phase until 15 min.
The conditions of ESI were introduced as follows: capillary voltage: 0.8 kV, sample cone voltage: 40.0
V, source temperature: 150 ◦C, desolvation temperature: 550 ◦C, cone gas flow: 50 L/h, and desolvation
gas flow: 1200 L/h. MS2 setting was kept at a collision energy (CE) of 30 eV.
4.5. Molecular Networking
The data of HR-ESI-LC-MS/MS of the crude extract were applied to create the network. At first,
the raw MS/MS data were converted to mzXML format using the MSConvert software. The data were
then uploaded to the Global Natural Products Social molecular networking (http://gnps.ucsd.edu)
platform using FileZilla (https://filezilla-project.org/) to create the network on the online workflow at
GNPS [15]. All MS2 peaks within +/− 17 Da of the precursor m/z were removed to filter for the data.
MS2 spectra were filtered by selecting only the top 6 peaks in the +/− 50 Da window throughout
the spectrum. All data were then networked with MS-Network with an MS2 fragment ion tolerance of
0.02 Da and a parent mass tolerance of 0.02 Da to create consensus spectra. Moreover, those including
less than two spectra of the consensus spectra were deleted. A cosine score above 0.6 and more than
three matched peaks were applied to create a network. Further, edges between two nodes were held
in the network if and only if each of the nodes arrived in each other’s respective top 10 most similar
nodes. The GNPS’ spectra library was used to filter the input data via library spectra due to similarities
in the database. The input data must follow at least six match peaks with a score above 0.7 in library
spectra to select as a matched output spectra. The output molecular networking data were visualized
using the Cytoscape (ver. 3.6.1) [48].
4.6. Bioactivity Assays
The antimicrobial activity was initially tested in vitro at a final concentration of 100 µg/mL against
the ESKAPE panel of multidrug-resistant bacterial human pathogens, including the Gram-positive
bacteria Enterococcus faecium (Efm, DSM 20477) and methillicin-resistant Staphylococcus aureus (MRSA,
DSM 18827), and the Gram-negative bacteria Acinetobacter baumannii (DSM 30007), Klebsiella pneumoniae
(DSM 30104), Escherichia coli (DSM 1576) and Pseudomonas aeruginosa (DSM 1128). Moreover, the activity
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of the samples against two human pathogen yeasts, Cryptococcus neoformans (DSM 6973) and Candida
albicans (DSM 1386), were performed. All test strains were bought from Leibniz Institute DSMZ-German
Collection of Microorganisms and Cell Cultures, Braunschweig, Germany. The cultivation of bacteria
took place in a TSB medium (0.5% NaCl, 1.2% tryptic soy broth), but E. faecium was grown in a M92
medium (3% trypticase soy broth, pH 7.0–7.2, 0.3% yeast extract). C. albicans was cultivated in M186/3
(0.1% malt extract, 0.17% peptone from soymeal, 0.3% glucose, 0.1% yeast extract) and C. neoformans
was grown in M186 (1% glucose, 0.5% peptone from soymeal, 0.3% malt extract, 0.3 yeast extract).
Overnight cultures of the test organisms were adjusted and diluted to an optical density (600 nm)
of 0.01–0.03. To prepare the assay, a stock solution of 20 mg/mL in DMSO was prepared for the test
samples and transferred into a 96-well microliter plate. A total of 200 µL of cell suspension cultures
were added to each well. The incubation of inoculated microplates was performed for 5 h at 37 ◦C
and 200 rpm (E. faecium without shaking), respectively, 28 ◦C and 200 rpm for 7 h for the C. neoformans.
The detection of inhibitory effects was performed by adding 10 µL of a resazurin solution (0.3 mg/mL
phosphate-buffered saline) to each cell and incubating again for 5–30 min. Then, 10 µL of a resazurin
solution was added to the microplates and incubated again for 5–30 min before the fluorescence signal
(560 nm/590 nm) was read by the microplate reader (Tecan Infinite M200). For E. faecium the pH
indicator bromocresol purple was used to determine the acidification caused by growing. For R.
solanacearum and C. neoformans, the optical density at 600 nm after the incubation time was recorded
using the microplate reader. Chloramphenicol was the positive control used for the bacteria, nystatin
for C. albicans and amphotericin B for C. neoformans. The IC50 values were calculated by Excel to
determine the concentration that shows 50% inhibition of the viability.
The anticancer activity was assessed against six human cancer cell lines, lung carcinoma cell line
A549 (CLS, Eppelheim, Germany), colorectal adenocarcinoma cell line HT29 (DSMZ, Braunschweig,
Germany), malignant melanoma cell line A375 (CLS, Eppelheim, Germany), liver cancer cell line Hep
G2 (DSMZ, Braunschweig, Germany), colon cancer cell line HCT116 (DSMZ, Braunschweig, Germany),
human breast cancer line MDA-MB231 (CLS, Eppelheim, Germany) and the non-cancerous human
keratinocyte cell line HaCaT (CLS, Eppelheim, Germany). The cytotoxic activity was evaluated by
monitoring the metabolic activity at 37 ◦C under a humidified atmosphere and 5% CO2 in CellTiterBlue
Cell Viability Assay (Promega, Mannheim, Germany). The cells of HT29, Hep G2 and HCT116 were
cultivated in an RPMI 1640 medium (Life Technologies, Darmstadt, Germany) with 10% fetal bovine
serum, 100 U/mL penicillin and 100 mg/mL streptomycin supplemented at 37 ◦C and 5% CO2, A549 cell
in DMEM: Ham’s F12 medium (1:1) supplemented with 15 mM HEPES as well as A375 and HCT116
cells in a DMEM medium supplemented with 4.5 g/L D-Glucose and 110 mg/L sodium pyruvate.
The seeding of cells was carried out in 96-well plates at a concentration of 10,000 cells per well for
bioactivity tests. For the experimental procedure, a stock solution of 40 mg/mL in DMSO was prepared
for each extract. Furthermore, 100 µL of fresh medium containing the test samples was replaced
with the medium in the cells and then all of the samples were prepared in duplicates. Growth media
and 0.5% DMSO were used as negative controls, while doxorubicin served as a positive control.
The samples were added to the cells, which were incubated for 24 h at 37 ◦C. The assay was performed
according to the manufacturer’s instructions (Promega), and measured using the microplate reader
Tecan Infinite M200 (Tecan, Crailshaim, Germany) at an excitation of 560 nm and an emission of 590
nm. The IC50 values were determined by 50% inhibition of cell viability according to negative control
(no compound) by Excel. Doxorubicin was the positive control.
5. Conclusions
By employing a state-of-the-art automated dereplication strategy such as MN in combination with
a traditional chemical profiling method, 1H NMR spectroscopy, we were able to unravel the chemical
machinery of the Persian Gulf sponge A. sinoxea. This approach, together with antimicrobial activity
assessments, enabled the purification and characterization of eight compounds from four different
natural product classes, which have never been reported from A. sinoxea before. We have also identified
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a new DKP (8), which is the enantiomer of another sponge-derived DKP. The known cholesterol
derivative 3 exerted moderate anti-MRSA activity, and this is the first report of such activity observed
with this compound. Overall, an integrated approach employing several metabolomics/profiling
techniques in a complementary manner can assist the identification and investigation of the real
chemical diversity of marine organisms to guide the discovery of their new and bioactive constituents.
This study further confirms the untapped potential of marine sponges in the Persian Gulf for marine
biodiscovery and stimulates future studies on these organisms.
Supplementary Materials: The following are available online at http://www.mdpi.com/1660-3397/18/7/366/s1.
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